Long-term intranasal oxytocin for female sexual dysfunction
Sexual function improved during both oxytocin and placebo periods, with no statistically significant treatment effect.
What this study tells us
Participants were assigned to comparison groups by chance, usually with placebo and/or blinding to reduce bias. This is a strong design for testing cause and effect, but the population, duration and endpoints still limit what can be concluded.
Pre- and postmenopausal women with sexual dysfunction
n=30
Sexual function improved during both oxytocin and placebo periods, with no statistically significant treatment effect.
Small sample with large placebo/context effect; does not establish oxytocin as an effective treatment for female sexual dysfunction.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Sexual function improved during both oxytocin and placebo periods, with no statistically significant treatment effect.